Glooko Appoints Mark Clements, M.D., Ph.D. as Chief Medical and Strategy Officer
2 Articles
2 Articles
Glooko Appoints Mark Clements, M.D., Ph.D. as Chief Medical and Strategy Officer
PALO ALTO, Calif.–(BUSINESS WIRE)–Glooko, a leading global diabetes data management company, today announced the appointment of Dr. Mark Clements as Chief Medical and Strategy Officer. Dr. Clements has served as Glooko’s fractional Chief Medical Officer since 2016 and will step into this expanded, full-time role designed to strategically integrate the company’s clinical vision, product roadmap, and data solutions to accelerate growth and innovat…
Glooko adds chief strategy officer to chief medical officer's title
Glooko announced today that it expanded the position of Dr. Mark Clements to make him its chief medical and strategy officer. Clements became the Palo Alto, California-based diabetes management company’s fractional chief medical officer in 2016. He now steps into an expanded, full-time role designed to integrate Glooko’s clinical vision, product roadmap and data solutions. His appointment aims to accelerate growth and innovation, according to a …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage